Douglas C. Bryant
President & CEO at QuidelOrtho Corporation
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: QuidelOrtho Corporation, 3 years.
QuidelOrtho Corporation
Director · President & CEO
Chief executive roles
QuidelOrtho Corporation
· President & CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 3, 2024 | QuidelOrtho Corporation | Grant or award | +3,795 | — | — |
| Feb 3, 2024 | QuidelOrtho Corporation | Shares withheld for tax | −1,924 | $68.34 | $131,486 |
| Feb 1, 2024 | QuidelOrtho Corporation | Grant or award | +1,116 | — | — |
| Feb 1, 2024 | QuidelOrtho Corporation | Shares withheld for tax | −566 | $69.45 | $39,309 |
| Jan 31, 2024 | QuidelOrtho Corporation | Grant or award | +6,761 | — | — |
| Jan 31, 2024 | QuidelOrtho Corporation | Shares withheld for tax | −2,476 | $68.51 | $169,631 |
| Jan 31, 2024 | QuidelOrtho Corporation | Grant or award | +12,093 | — | — |
| Jan 31, 2024 | QuidelOrtho Corporation | Shares withheld for tax | −4,954 | $68.51 | $339,399 |
| Aug 24, 2023 | QuidelOrtho Corporation | Grant or award | +1,461 | — | — |
| Aug 24, 2023 | QuidelOrtho Corporation | Shares withheld for tax | −725 | $78.33 | $56,789 |
| Feb 23, 2023 | QuidelOrtho Corporation | Grant or award | +15,180 | — | — |
| Feb 23, 2023 | QuidelOrtho Corporation | Shares withheld for tax | −7,527 | $88.71 | $667,720 |
| Feb 11, 2023 | QuidelOrtho Corporation | Grant or award | +7,309 | — | — |
| Feb 11, 2023 | QuidelOrtho Corporation | Shares withheld for tax | −3,453 | $86.50 | $298,685 |
| Feb 11, 2023 | QuidelOrtho Corporation | Grant or award | +2,192 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.